Page last updated: 2024-10-18

dihydroxyphenylalanine and Stuttering

dihydroxyphenylalanine has been researched along with Stuttering in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Stuttering: A disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual's age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. (From DSM-IV, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, JC1
Maguire, G1
Riley, G1
Lee, A1
Keator, D1
Tang, C1
Fallon, J1
Najafi, A1

Other Studies

1 other study available for dihydroxyphenylalanine and Stuttering

ArticleYear
Increased dopamine activity associated with stuttering.
    Neuroreport, 1997, Feb-10, Volume: 8, Issue:3

    Topics: Adult; Amygdala; Brain; Cerebral Cortex; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; H

1997